In the attached pdf-document you will find more detailed information on the distribution of the dividend and the resolution on the appropriation of the balance sheet profit for the year 2021.
In 1988, Mr Nau successfully completed his training in wholesale and foreign trade. Several years of work abroad in Mexico, the US and Singapore for Haarmann & Reimer GmbH, a former Bayer AG subsidiary (now Symrise AG), followed his training in Hamburg.
In July 2000, he joined BMP GmbH, where he has been Managing Director since January 2004. In October 2008, he was appointed Managing Director of the newly founded BMP Biotec GmbH, followed by his appointment to the Management Board of BMP Pharma Trading AG in July 2012. On the Management Board of BMP Pharma Trading AG, Mr Nau is responsible for the trading business and quality assurance.
Mr Nau is best known for his network in the pharmaceutical and food industries, created over the course of 20 years, a sense for new trends in the markets and last but not least for continuity and sustainability.
Since 17 June 2021, Mr Nau has been the Chief Executive Officer of BMP Pharma Trading AG.
Born in 1959, Peter Rudolf Wieland holds a degree in the field of business administration. His professional focus includes finance and accounting, as well as controlling. He has several years of experience at the management level in an international environment.
Since December 2008, Mr Wieland has been the commercial managing director of
B.M.P., Bulk Medicines & Pharmaceuticals GmbH.
Starting 19 July 2021, Mr Wieland became Chief Financial Officer of BMP Pharma Trading AG.
Mr Westphalen is a tax consultant and partner at
After graduating from high school and serving in the German Armed Forces, Mr Westphalen studied business administration at the University of Hamburg, completing his studies with a diploma.
After working for 3 years as an auditing assistant for a reputable auditing company in Hamburg, he was appointed as a tax consultant in the mid-1980s after passing his professional examinations. In the same year, Mr Westphalen founded his first tax consultancy firm in Hamburg together with a colleague.
In addition to his work as a tax consultant, Mr Westphalen is
Mr Voigt began his career as a product manager/trader at Helm AG, Hamburg, one of the world’s largest chemical trading companies for almost a decade. He now has over 30 years of experience in trading chemical products in Europe. In 1996, Mr Voigt started as Sales Manager at the MCP Group and advanced to Managing Director of MCP HEK in Germany in 2008.
Mr Voigt is a graduate of the European Business School and has been a member of the Supervisory Board since August 2013.
On 7 July 2016, Mr Voigt assumed the function of Deputy Chair of the Supervisory Board of BMP Pharma Trading AG.
recent News:
In the attached pdf-document you will find more detailed information on the distribution of the dividend and the resolution on the appropriation of the balance sheet profit for the year 2021.
upcoming Trade Fair:
copyright
BMP Pharma Trading AG